(Q111459296)

2

0 references

Volodymyr Gerzanich

3

0 references

Mohamed Nasr

4

0 references

Qiyi Tang

5

0 references

J Marc Simard

6

0 references

Richard Y Zhao

Frontiers in Microbiology

7

0 references

language of work or name

English

0 references

publication date

2022

0 references

published in

0 references

volume

13

0 references

page(s)

854567

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

9 March 2022

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It?

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Disease-specific B Cell epitopes for serum antibodies from patients with severe acute respiratory syndrome (SARS) and serologic detection of SARS antibodies by epitope-based peptide antigens

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The J-domain protein Rme-8 interacts with Hsc70 to control clathrin-dependent endocytosis in Drosophila

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Emodin inhibits current through SARS-associated coronavirus 3a protein

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Coronavirus genomics and bioinformatics analysis

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Characterization of the 3a protein of SARS-associated coronavirus in infected vero E6 cells and SARS patients.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The human PDZome: a gateway to PSD95-Disc large-zonula occludens (PDZ)-mediated functions

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Severe acute respiratory syndrome coronavirus Orf3a protein interacts with caveolin

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Autophagy during viral infection - a double-edged sword.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The Genome sequence of the SARS-associated coronavirus

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Continuous and Discontinuous RNA Synthesis in Coronaviruses

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Anti-tumor activity mediated by protein and peptide transduction of HIV viral protein R (Vpr).

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Assessment of the Toll-like receptor 3 pathway in endosomal signaling

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Pyroptotic cell death defends against intracellular pathogens

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The YXXΦ motif within the severe acute respiratory syndrome coronavirus (SARS-CoV) 3a protein is crucial for its intracellular transport

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Accessory proteins of SARS-CoV and other coronaviruses

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Roles of reactive oxygen species in cell signaling pathways and immune responses to viral infections

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

An inflammatory cytokine signature predicts COVID-19 severity and survival

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

G3BP1 inhibits RNA virus replication by positively regulating RIG-I-mediated cellular antiviral response

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Positive Selection of ORF1ab, ORF3a, and ORF8 Genes Drives the Early Evolutionary Trends of SARS-CoV-2 During the 2020 COVID-19 Pandemic

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

A new coronavirus associated with human respiratory disease in China

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Finding the Middle Ground for Autophagic Fusion Requirements

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

ORF3a mutation associated higher mortality rate in SARS-CoV-2 infection

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Tissue damage from neutrophil-induced oxidative stress in COVID-19

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Coronavirus Proteins as Ion Channels: Current and Potential Research

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Different mutations in SARS-CoV-2 associate with severe and mild outcome

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Targeting the NLRP3 Inflammasome in Severe COVID-19

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Variations in Orf3a protein of SARS-CoV-2 alter its structure and function

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

SARS-Cov-2 ORF3a: Mutability and function

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

A recent origin of Orf3a from M protein across the coronavirus lineage arising by sharp divergence

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Unification and extensive diversification of M/Orf3-related ion channel proteins in coronaviruses and other nidoviruses

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Involvement of Oxidative Stress and the Innate Immune System in SARS-CoV-2 Infection

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

SARS-CoV-2: from its discovery to genome structure, transcription, and replication

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Single-Agent and Fixed-Dose Combination HIV-1 Protease Inhibitor Drugs in Fission Yeast ()

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Manipulation of autophagy by SARS-CoV-2 proteins

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

An easy pipeline for one-step purification of SARS-CoV-2 nucleocapsid protein from insect cell suspension culture

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

In-Frame 12-Nucleotide Deletion within Open Reading Frame 3a in a SARS-CoV-2 Strain Isolated from a Patient Hospitalized with COVID-19

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Covid-19: Solely refusing vaccine will not trigger a fitness to practise investigation, says GMC

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Single-Cell Analysis Reveals Characterization of Infiltrating T Cells in Moderately Differentiated Colorectal Cancer

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Emergence of Omicron third lineage BA.3 and its importance

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

A Bayesian approach to modeling antimicrobial multidrug resistance

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

HIF-1α is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The ER stress sensor IRE1 and MAP kinase ERK modulate autophagy induction in cells infected with coronavirus infectious bronchitis virus

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by Disrupting Viral Integrity

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Severe COVID-19: NLRP3 Inflammasome Dysregulated

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The ORF3a protein of SARS-CoV-2 induces apoptosis in cells

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Host PDZ‐containing proteins targeted by SARS‐CoV‐2

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The coding capacity of SARS-CoV-2

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Hypoxia: A key feature of COVID-19 launching activation of HIF-1 and cytokine storm

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The Hippo pathway: regulators and regulations

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Potential enhancement of osteoclastogenesis by severe acute respiratory syndrome coronavirus 3a/X1 protein

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

PDZ domains and their binding partners: structure, specificity, and modification

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Molecular pathways in virus-induced cytokine production

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

2 April 2022

Yeast for virus research

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Amino terminus of the SARS coronavirus protein 3a elicits strong, potentially protective humoral responses in infected patients

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

In vivo functional characterization of the SARS-Coronavirus 3a protein in Drosophila.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The ion channel activity of the SARS-coronavirus 3a protein is linked to its pro-apoptotic function.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The Severe Acute Respiratory Syndrome (SARS)-coronavirus 3a protein may function as a modulator of the trafficking properties of the spike protein

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Viroporins: structure and biological functions.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Membrane rearrangements mediated by coronavirus nonstructural proteins 3 and 4.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

A di-acidic signal required for selective export from the endoplasmic reticulum

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The severe acute respiratory syndrome coronavirus 3a is a novel structural protein.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Subcellular localization and membrane association of SARS-CoV 3a protein.

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The 3a Protein of SARS-coronavirus Induces Apoptosis in Vero E6 Cells

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567

Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease

2 April 2022

1 reference

https://api.crossref.org/works/10.3389/fmicb.2022.854567